SPC Logo

Boots Catarrh Pastilles

Last Updated on eMC 11-Nov-2013 View changes  | THE BOOTS COMPANY PLC Contact details

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Please click on the link to the left to view the PIL in PDF format.

Text only version for the visually impaired
Below is a text only representation of the Patient Information leaflet. The original may contain images or tables and can be viewed in PDF format using the link to the left. This PIL may be available from the RNIB in large print, Braille or audio CD. For further information please call the RNIB Medicine Leaflet line on 0800 198 5000. The product code(s) for this leaflet is/are: PL 00094/0009.



Boots Catarrh Pastilles

PATIENT INFORMATION LEAFLET

FRONT OF PACK

Boots Catarrh Pastilles

Eucalyptus Oil, Menthol, Pumilio Pine Oil

Soothing relief for coughs and catarrh

45 g e

BACK OF PACK

Read all of this carton for full instructions.

What this medicine is for

This medicine contains Menthol, Eucalyptus and Pumilio oils, which relieve chesty coughs and have antiseptic properties. It can be used to relieve the symptoms of congestion caused by catarrh, coughs and colds.

Before you take this medicine

Do not take:

  • If you are allergic to any of the ingredients
  • If you have an intolerance to some sugars, unless your doctor tells you to (this medicine contains glucose and sucrose)

Talk to your pharmacist or doctor:

  • If you are pregnant or breastfeeding

Information about some of the ingredients: Each pastille contains a total of 0.5 g of glucose and sucrose. This should be taken into account by people with diabetes. The colour E122 in this medicine may cause allergic reactions.

How to take this medicine

Check the inner bag is not broken before use. If it is, do not use the pastilles.

Adults and children of 12 years and over: One pastille when you need to. Don’t take more than 20 pastilles in 24 hours.

Suck each pastille slowly until it dissolves.

Do not give to children under 12 years.

Do not take more than the amount recommended above.

If symptoms do not go away, talk to your doctor.

If you take too many pastilles: Talk to a pharmacist or doctor straight away.

Possible side effects

Most people will not have problems, but some may get some.

If you get any of these serious side effects, stop taking the pastilles. See a doctor at once:

  • Difficulty in breathing, swelling of the face, neck, tongue or throat (severe allergic reactions)

If any side effect becomes severe, or you notice any side effect not listed here, please tell your pharmacist or doctor.

How to store this medicine

Do not store above 25°C. Store in the original package.

Keep all medicines out of the sight and reach of children.

Use by the date on the end flap of the carton.

Active ingredients

Each pastille contains Eucalyptus Oil 0.022% v/w, Menthol 0.813% w/w, Pumilio Pine Oil 0.604% v/w.

Also contains: sucrose, liquid glucose, modified starch (maize, tapioca), thymol, marshmallow root liquid extract, carmoisine (E122), vegetable oil, beeswax, water.

PL 00094/0009

Text prepared 8/13

Manufactured for

The Boots Company PLC
Nottingham
NG2 3AA

by The Marketing Authorisation holder

Ernest Jackson & Co
Crediton
Devon
EX17 3AP

If you need more advice ask your pharmacist.

Company contact details

THE BOOTS COMPANY PLC

Company image
Address

1 Thane Road West, Beeston, Nottingham, NG2 3AA

Fax

+44 (0)1159 592 565

Telephone

+44 (0)1159 595 165

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

eucalyptus oil, menthol, pumilio pine oil

Legal categories

GSL - General Sales List

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue